NVP-TAE 226, 99%

Name: NVP-TAE 226, 99% | 761437-28-9
Brand: J&K Chemical
SKU: JK1593743_10_MG
Price: 209.8 USD
Availability: InStock

Cat. No JK1593743_10_MG

Vendor: J&K Chemical

Product Information

Product Name

NVP-TAE 226, 99%

Brand Name

J&K

Product Number

1593743

CAS

761437-28-9

Molecular Formula

C23H25ClN6O3

Molecular Weight

468.94

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9934347

IUPAC Name

2-5-chloro-2-(2-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-ylamino-N-methylbenzamide

InChI Key

UYJNQQDJUOUFQJ-UHFFFAOYSA-N

SMILES

CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCOCC4)OC

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Publication Name: Nucleic Acids Research

Publication Date: 2024-11-22

DOI: 10.1093/nar/gkae1075

Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors

Publication Name: Bioorganic & Medicinal Chemistry

Publication Date: 2024-01-15

DOI: 10.1016/j.bmc.2023.117561

Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2023-12-15

DOI: 10.1016/j.ejmech.2023.115879

Design, synthesis, and biological evaluation of diaminopyrimidine derivatives as novel focal adhesion kinase inhibitors

Publication Name: RSC Medicinal Chemistry

Publication Date: 2023-11-15

DOI: 10.1039/d3md00324h

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Publication Name: Cancer Letters

Publication Date: 2023-08-01

DOI: 10.1016/j.canlet.2023.216284

NVP-TAE 226, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors

Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency

Design, synthesis, and biological evaluation of diaminopyrimidine derivatives as novel focal adhesion kinase inhibitors

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

NVP-TAE 226, 99%

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

NVP-TAE 226, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors

Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency

Design, synthesis, and biological evaluation of diaminopyrimidine derivatives as novel focal adhesion kinase inhibitors

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

NVP-TAE 226, 99%

Related Product

#title#

Login

Register